{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T14:28:27Z","timestamp":1778509707296,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203953"],"award-info":[{"award-number":["82203953"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304689"],"award-info":[{"award-number":["82304689"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejphar.2025.177988","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T06:40:27Z","timestamp":1753166427000},"page":"177988","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Systemic administration of Neochamaejasmin B inhibits mast cell activation to reduce inflammation in a rosacea mouse model by targeting MRGPRX2"],"prefix":"10.1016","volume":"1003","author":[{"given":"Yi","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3487-7025","authenticated-orcid":false,"given":"Mengyao","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1075-5557","authenticated-orcid":false,"given":"Yifan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delu","family":"Che","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.177988_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/bs.ai.2017.06.002","article-title":"Emerging roles for MAS-related G protein-coupled Receptor-X2 in host defense peptide, opioid, and neuropeptide-mediated inflammatory reactions","volume":"136","author":"Ali","year":"2017","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.ejphar.2025.177988_bib2","first-page":"6","article-title":"Expressions of MMP2, MMP9, and TIMP-1 in the inflammatory cells of nasal polyps: granulocytes, monocytes, and mast cells","volume":"27","author":"Bayar Muluk","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2025.177988_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109063","article-title":"Clarithromycin-treated chronic spontaneous urticaria with the negative regulation of Fc\u03b5R\u0399 and MRGPRX2 activation via CD300f","volume":"110","author":"Che","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2025.177988_bib4","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/ptr.7445","article-title":"Dehydroandrographolide targets CD300f and negatively regulated MRGPRX2-induced pseudo-allergic reaction","volume":"36","author":"Che","year":"2022","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejphar.2025.177988_bib5","doi-asserted-by":"crossref","first-page":"8737","DOI":"10.1038\/s41467-024-52946-7","article-title":"Single-cell transcriptomics reveals aberrant skin-resident cell populations and identifies fibroblasts as a determinant in rosacea","volume":"15","author":"Chen","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2025.177988_bib6","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020671","article-title":"Association of rosacea with cardiovascular disease: a retrospective cohort study","volume":"10","author":"Choi","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ejphar.2025.177988_bib7","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202013560","article-title":"A positive feedback loop between mTORC1 and cathelicidin promotes skin inflammation in rosacea","volume":"13","author":"Deng","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ejphar.2025.177988_bib8","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1001\/jamadermatol.2024.0636","article-title":"Rosacea core domain set for clinical trials and practice: a consensus statement","volume":"160","author":"Dirr","year":"2024","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.ejphar.2025.177988_bib9","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/exd.13378","article-title":"Autoantigens ADAMTSL5 and LL37 are significantly upregulated in active psoriasis and localized with keratinocytes, dendritic cells and other leukocytes","volume":"26","author":"Fuentes-Duculan","year":"2017","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.ejphar.2025.177988_bib10","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2014.05.004","article-title":"Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria","volume":"134","author":"Fujisawa","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2025.177988_bib11","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/12034754241229365","article-title":"Rosacea: pathogenesis and therapeutic correlates","volume":"28","author":"Geng","year":"2024","journal-title":"J. Cutan. Med. Surg."},{"key":"10.1016\/j.ejphar.2025.177988_bib12","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1002\/ptr.7447","article-title":"Luteolin inhibits Fc\u03b5R\u0399- and MRGPRX2-mediated mast cell activation by regulating calcium signaling pathways","volume":"36","author":"Hao","year":"2022","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejphar.2025.177988_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106258","article-title":"Imiquimod-related dermatitis is mainly mediated by mast cell degranulation via Mas-related G-protein coupled receptor B2","volume":"81","author":"Hao","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2025.177988_bib14","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jid.2020.08.013","article-title":"Paired transcriptomic and proteomic analysis implicates IL-1\u03b2 in the pathogenesis of papulopustular rosacea explants","volume":"141","author":"Harden","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejphar.2025.177988_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jid.2023.06.201","article-title":"Mast cells initiate type 2 inflammation through tryptase released by MRGPRX2\/MRGPRB2 activation in atopic dermatitis","volume":"144","author":"Jia","year":"2024","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.ejphar.2025.177988_bib37","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s10787-025-01639-8","article-title":"Casticin reduces rosacea-related inflammation by inhibiting mast cell activation via Mas-related G protein-coupled receptor X2","volume":"33","author":"Jia","year":"2025","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ejphar.2025.177988_bib16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.intimp.2018.04.008","article-title":"A new flavonoid from Stellera chamaejasme L., stechamone, alleviated 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in a murine model","volume":"59","author":"Jo","year":"2018","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177988_bib17","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/jdv.20249","article-title":"Beyond the classic players: mas-Related G protein-coupled receptor member X2 role in pruritus and skin diseases","volume":"39","author":"Kumar","year":"2025","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.ejphar.2025.177988_bib18","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/jdv.20249","article-title":"Beyond the classic players: mas-Related G protein-coupled receptor member X2 role in pruritus and skin diseases","volume":"39","author":"Kumar","year":"2025","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.ejphar.2025.177988_bib19","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jaci.2022.12.805","article-title":"Novel small molecule MRGPRX2 antagonists inhibit a murine model of allergic reaction","volume":"151","author":"Kumar","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2025.177988_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113386","article-title":"Biflavonoid-rich fraction from Daphne pseudomezereum Var. koreana hamaya exerts anti-inflammatory effect in an experimental animal model of allergic asthma","volume":"265","author":"Lee","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejphar.2025.177988_bib21","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.immuni.2019.03.013","article-title":"Activation of mast-cell-expressed mas-related G-Protein-Coupled receptors drives non-histaminergic itch","volume":"50","author":"Meixiong","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.ejphar.2025.177988_bib22","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jare.2024.06.013","article-title":"Targeting the STAT3\/IL-36G signaling pathway can be a promising approach to treat rosacea","volume":"71","author":"Meng","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.ejphar.2025.177988_bib23","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ijpharm.2015.10.038","article-title":"Neochamaejasmin B increases the bioavailability of chamaechromone coexisting in Stellera chamaejasme L. via inhibition of MRP2 and BCRP","volume":"496","author":"Pan","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejphar.2025.177988_bib24","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jaad.2015.07.009","article-title":"Rosacea is associated with chronic systemic diseases in a skin severity-dependent manner: results of a case-control study","volume":"73","author":"Rainer","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejphar.2025.177988_bib25","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1016\/j.jid.2022.05.005","article-title":"Role of MrgprB2 in rosacea-like inflammation in mice: modulation by \u03b2-Arrestin 2","volume":"142","author":"Roy","year":"2022","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejphar.2025.177988_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/life13081654","article-title":"Antioxidant and anti-inflammatory activities of Stellera chamaejasme L. roots and aerial parts extracts","volume":"13","author":"Selenge","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.ejphar.2025.177988_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ph17020212","article-title":"Recent advances in the management of rosacea through natural compounds","volume":"17","author":"Semenescu","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.ejphar.2025.177988_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114091","article-title":"Dietary supplementation of n-3 PUFAs ameliorates LL37-induced rosacea-like skin inflammation via inhibition of TLR2\/MyD88\/NF-\u03baB pathway","volume":"157","author":"Shen","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2025.177988_bib29","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.jaad.2020.01.077","article-title":"Standard management options for rosacea: the 2019 update by the national rosacea society expert committee","volume":"82","author":"Thiboutot","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejphar.2025.177988_bib30","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/cmi.2009.43","article-title":"NF-kappaB signaling pathway, inflammation and colorectal cancer","volume":"6","author":"Wang","year":"2009","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ejphar.2025.177988_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1406438","article-title":"MRGPRX2 antagonist GE1111 attenuated DNFB-Induced atopic dermatitis in mice by reducing inflammatory cytokines and restoring skin integrity","volume":"15","author":"Wong","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.177988_bib32","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.3892\/mmr.2017.6215","article-title":"Activation-induced upregulation of MMP9 in mast cells is a positive feedback mediator for mast cell activation","volume":"15","author":"Xu","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejphar.2025.177988_bib33","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm1616","article-title":"Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea","volume":"13","author":"Yamasaki","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2025.177988_bib34","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1096\/fj.06-6075com","article-title":"Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin","volume":"20","author":"Yamasaki","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2025.177988_bib35","article-title":"Signaling pathways and targeted therapy for rosacea","volume":"15","author":"Yang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.177988_bib36","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/jocd.14164","article-title":"Murine models of rosacea: a review","volume":"21","author":"Zhang","year":"2022","journal-title":"J. Cosmet. Dermatol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925007423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925007423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:51:59Z","timestamp":1772751119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925007423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":37,"alternative-id":["S0014299925007423"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177988","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic administration of Neochamaejasmin B inhibits mast cell activation to reduce inflammation in a rosacea mouse model by targeting MRGPRX2","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177988","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177988"}}